Pediatr. praxi. 2012;13(4):239-242

The position of pediatrics in cervical cancer prevention

MUDr.Tomáš Fait, Ph.D.
Gynekologicko-porodnická klinika 1. LF UK a VFN Praha

The benefit of HPV vaccination is clear. The risk of cervical carcinoma decreases. It may be seen after some years. Vaccination is followed could

be decrease in incidence of cervical, vulval and vaginal laesions and other HPV related diseases, but it is according to HPV vaccination types.

Keywords: HPV infection, HPV vaccination, cervical cancer

Published: August 24, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fait T. The position of pediatrics in cervical cancer prevention. Pediatr. praxi. 2012;13(4):239-242.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis. Laryngoskope 2008; 118: 1236-1247. Go to original source... Go to PubMed...
    2. Bosch FX, Castellsague X, Sanjosé S. HPV and cervical cancer: screening or vaccination. Br J of Cancer 2008; 98: 15-21. Go to original source... Go to PubMed...
    3. de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology 2004; 324: 17-27. Go to original source... Go to PubMed...
    4. FUTURE II Study Group: Quadrivalent Vaccine against HPV to prevent high-grade cervical lesions. NEJM 2007; 356,19: 1915-1927. Go to original source... Go to PubMed...
    5. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against HPV to prevent anogenital disease (FUTURE I). N Engl J Med 2007; 356, 19: 1928-1943. Go to original source... Go to PubMed...
    6. Giannini SL, Hanon E, Moris P, et al. Enhanced humoral and memory B cellular immunity using HPV 16/18 LV VLP vaccine formulated with the MLP/aluminium salt combination (AS04) compared to aluminium salt only. Vaccine 2006; 24: 5937-5949. Go to original source... Go to PubMed...
    7. Paavonen J, Naud P, Salmerón J, et al. Efficacy of HPV-16/8 ASO4-adjuvated vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA). Lancet 2009; 374: 301-314. Go to original source... Go to PubMed...
    8. David MP, Van Herck K, Hardt K, et al. Long-term persistence of anti HPV-16 and -18 antibodies induced by vaccination with ASO4-adjuvanted cervical cancer vaccine. Gynecol Oncol 2009; 115: S 1-6. Go to original source... Go to PubMed...
    9. Einsterin MH, Baron M, Levin MJ, et al. Comparison of the immunogenicity and safety of Cervarix and Gardasil HPV cervical cancer vaccines in healthy women aged 18-45 years. Hum Vaccin 2009; 5: 705-719. Go to original source... Go to PubMed...
    10. Olsson SE, Villa LL, Costa LR, et al. Induction of immune memory following administration of a prophylactic quadrivalent HPV types 6/11/16/18 L1 VLP vaccine. Vaccine 2007; 25: 4931-4939. Go to original source... Go to PubMed...
    11. Harper M, Paavonen J. Age for HPV vaccination. Vaccine 2008; 265: A7-11. Go to original source... Go to PubMed...
    12. Muńoz N, Manalastas R, Pitisuttithum P, et al. Safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet 2009; 373: 1949-1957. Go to original source... Go to PubMed...
    13. Guiliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and dinase in males. NEJM 2011; 364: 401-411. Go to original source... Go to PubMed...
    14. Tomljenovic L, Shaw CA. Mechanism of aluminum adjuvant toxicity and autoimmunity in pediatric population. Lupus 2012; 21(2): 223-230. Go to original source... Go to PubMed...
    15. Fairley CK, Hocking JS, Gurring LC, et al. Rapid decline in presentations of genital warts ater the implementation of a national quadrivalent HPV vaccination programme for young women. Sex Transm Infect 2009; 0: 1-4.
    16. Brotherton JM, Fridman M, May CL, et al. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377: 2085-2092. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.